[Comparative clinical study of Neopanpur and Creon].
The aim of the study was to compare the clinical efficacy of Neopanpur (EGIS) and Creon (Kalichemie) in patients with chronic pancreatitis. Fifteen patients were examined for 2 x 10 days. A period: Neopanpur 3 x 2, B period: Creon 10,000 3 x 2. The type of the trial was: randomized, open, crossover study. The complaints of the patients (in score), the characters of the stool (daily weight, fat content, foamy, smell), amylum tolerance test (ATT), H2-breath test, lipjodol-test, Lundh-test and Schilling-test were determined before and during the treatment periods. Both enzyme preparations could effectively decrease the anamnestic complaints, the stool frequency and characteristics together with the laboratory results of pancreatic functions. There is no clinically significant difference between the clinical efficacy of Creon and Neopanpur. Both enzyme preparations can be applied in the treatment of maldigestion in patients with chronic pancreatic insufficiency.
Beró
T
T
Pécsi Orvostudományi Egyetem I. sz. Belgyógyászati Klinika.
Jávor
T
T
D000328:Adult; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008049:Lipase / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010184:Pancreatic Extracts / Q000627:therapeutic use*; D010195:Pancreatitis / Q000188:drug therapy*; D020799:Pancrelipase
C085343:Neopanpur; D010184:Pancreatic Extracts; D020799:Pancrelipase; D008049:Lipase
Neopanpur és Kreon összehasonlító klinikai vizsgálata.